MACULAR DEGENERATION
Clinical trials for MACULAR DEGENERATION explained in plain language.
Never miss a new study
Get alerted when new MACULAR DEGENERATION trials appear
Sign up with your email to follow new studies for MACULAR DEGENERATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gene therapy for dry AMD shows promise but trial halted early
Disease control TerminatedThis early-phase study tested a single injection of GT005 gene therapy in 56 people with dry age-related macular degeneration (AMD), a leading cause of vision loss. The goal was to check safety and how well the treatment worked. The trial was stopped early, but results help guide…
Matched conditions: MACULAR DEGENERATION
Phase: PHASE1, PHASE2 • Sponsor: Gyroscope Therapeutics Limited • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New eye scanner software could sharpen diagnosis of retinal diseases
Diagnosis TerminatedThis study tested a new software called AngioScan on 150 people with retinal disorders like macular degeneration. The goal was to see if it improves image quality and helps doctors diagnose and treat eye diseases better. The software is not yet FDA approved, but the camera it use…
Matched conditions: MACULAR DEGENERATION
Sponsor: University of California, Los Angeles • Aim: Diagnosis
Last updated May 14, 2026 12:03 UTC